XWELL, Inc. (XWEL)

Market Cap	11.18M +172.6%
Revenue (ttm)	29.21M -13.8%
Net Income	-28.23M
EPS	-5.08
Shares Out	7.93M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,359
Open	1.490
Previous Close	1.470
Day's Range	1.390 - 1.490
52-Week Range	0.255 - 2.200
Beta	1.01
Analysts	Buy
Price Target	7.00 (+396.45%)
Earnings Date	May 21, 2026

About XWEL

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler’s spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircra...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 280
• Stock Exchange: NASDAQ
• Ticker Symbol: XWEL
• Website: https://www.xwell.com

Financial Performance

In 2025, XWELL's revenue was $29.21 million, a decrease of -13.83% compared to the previous year's $33.90 million. Losses were -$28.23 million, 67.5% more than in 2024.

Analyst Summary

According to one analyst, the rating for XWEL stock is "Buy" and the 12-month stock price target is $7.0.

Price Target

$7.0

(396.45% upside)

Analyst Consensus: Buy